Ann & Robert H Lurie Children's Hospital of Chicago
Chicago, Illinois, 60611, United States
NCT Number: NCT06359951
This study tests a suite of single-session intervention (SSI) targeting risk factors for depression and eating disorders among adolescents and young adults. Youth ages 13-25 who screen positive for depression or anxiety as a part of routine care will be offered one of three digital SSIs. Participants will complete questionnaires before the intervention, immediately after the intervention, and 3-months after completing the intervention so that the study team can investigate if Project YES leads to reductions in depression, anxiety, as well as eating disorder symptoms.
Looking for future studies?
Notify Me13 year–25 year
All sexes
Interventional
Not applicable
Chicago, Illinois, 60611, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Digital SSI
Time frame: Pre-Intervention (baseline), immediately after the intervention, 12-week follow-up
A 13-item questionnaire designed to assess depressive symptoms in youth. Total scores range from 0 to 26, with higher scores indicating greater depression severity (primary outcome).
Time frame: Pre-Intervention (baseline), 12-week follow-up
A 9 item questionnaire that objectifies and assesses degree of depression severity. Total scores range from 0 to 27, with higher scores indicating greater depression severity.
Time frame: Pre-Intervention (baseline), 12-week follow-up
A 7 item questionnaire that measures severity of anxiety, mainly in outpatients. Total scores range from 0 to 21, with higher scores indicating greater anxiety severity.
Time frame: Pre-Intervention (baseline), immediately after the intervention, 12-week follow-up
This is a a single-item screener designed to identify individuals recently engaging in problematic restriction. The single item is "Have there been any times within the past month when you have eaten in this manner because you were concerned about your body shape and/or weight?" and has participants respond with a yes or a no.
Time frame: Pre-Intervention (baseline), immediately after the intervention, 12-week follow-up
The 3-item State Hope Scale is a a dispositional self-report measure of agency. This scale can range from 3 to 24, with higher scores indicating higher levels of agency thinking.
Time frame: Pre-Intervention (baseline), immediately after the intervention, 12-week follow-up
The 7-item Self-Hate Scale is a brief, psychometrically valid measure of self-hate. Total scores are calculated as the mean of all items and scores are coded such that higher ratings indicate higher levels of self-hate (range 1-7).
Time frame: Pre-Intervention (baseline), immediately after the intervention, 12-week follow-up
This four-item scale measures major aspects of hopelessness using true/false questions examining the respondent's attitude for the past week. This scale ranges from 0-4 such that higher scores reflect higher levels of hopelessness.
Time frame: Immediately after the intervention
The program feedback scale asks participants to rate agreement with seven statements indicating perceived acceptability and feasibility of their selected SSI (eg, "I enjoyed the program") on a 5-point Likert scale (1="really disagree"; 5="totally agree"). Means and standard deviations are calculated for each item (range 0-7), with a mean of 3.5 for each item indicating acceptability and feasibility.
Ann & Robert H Lurie Children's Hospital of Chicago
Other
Implementation of Digital Brief, Scalable Single Session Interventions in Specialty Adolescent Care
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06013137
Anxiety, Anxiety Disorders
Lebanon, New Hampshire, United States
View Trial DetailsNCT02573246
Anxiety, Anxiety Disorders
Durham, North Carolina, United States
View Trial DetailsNCT02450240
Anxiety, Anxiety Disorders
Tulsa, Oklahoma, United States
View Trial DetailsNCT02021344
Anxiety, Anxiety Disorders
Ann Arbor, Michigan, United States
View Trial Details